Understanding of host–tumor immune reaction led to the discovery of antibodies against immune checkpoint proteins, such as programmed death 1 (PD-1), its ligand PD-L1 and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) [90]. The gene discussed is CD274; the disease is neoplasm.